LYN and non-small cell lung carcinoma: These mutation rates were consistent with the incidences observed in the general NSCLC patient population, and EGFR mutations did not correlate with LYN expression status in non-smoker, female patients with ADC (P > 0.05, Supplementary Table S4) [24–26].